Sinofn Health
Sinofn Health
The global dietary supplement landscape is undergoing a paradigm shift. Moving beyond simple formulation, the industry now demands Precision Nutraceuticals, data-backed bioavailability, and full supply chain transparency. SINOFN Health operates at the intersection of clinical research and industrial scalability, positioning ourselves as not just a manufacturer, but a strategic partner for global supplement brands.
With an aging global population and rising health consciousness, the demand for FSMP (Foods for Special Medical Purposes) and functional ingredients has surged. We bridge the gap between high-level R&D and consumer-ready products.
Our roadmap focuses on "Intelligent Nutrition." By leveraging AI in formulation and molecular stability testing, we reduce the time-to-market for complex blends, ensuring that your private label products are always ahead of the trend curve.
Navigating the maze of international regulations (FDA, EFSA, NMPA) is our core competency. We ensure every batch meets destination-market standards, mitigating risks for global distributors.
SINOFN Health Co., Ltd., established in 2025 as the trading arm of the 2012-founded SINOFN Group, is a beacon of scientific excellence. Backed by the Chinese Academy of Sciences, our heritage is built on rigid scientific inquiry rather than mere mass production.
Founder Mrs. GuoHong Liu has transformed the approach to metabolic disorder management, particularly for PKU patients, by prioritizing accessibility and formulation stability. This "Profit with Purpose" philosophy underpins our manufacturing ethics.
Medical Innovation Director, Peking University MD. Expert in metabolic formulations.
CAS Postdoc, Specialist in bioactive delivery systems.
Senior Scientist, EU Regulatory & Nutraceutical Tech specialist.
At SINOFN, quality is a continuous process, not a final check. Our facility integration spans from raw material procurement to blockchain-enabled batch tracking.
We manage 10+ dedicated lines including softgels, gummies, and powders, with an annual capacity exceeding 500M units, fully certified by international standards.
Yes. Our R&D center provides pilot-scale prototyping for tablets, capsules, and liquids, allowing you to test formulations before full-scale manufacturing.
Yes. We offer scalable manufacturing solutions, tailoring our support to meet the specific compliance and volume needs of both emerging startups and global brands.
We provide global localization support, navigating regulatory frameworks in the EU, USA, and Asia, ensuring your product enters the target market seamlessly.
